Overview

Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia

Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess longer term safety and effectiveness of Dysport®.
Phase:
Phase 3
Details
Lead Sponsor:
Ipsen
Treatments:
abobotulinumtoxinA
Botulinum Toxins, Type A
incobotulinumtoxinA
onabotulinumtoxinA